03-06 Nova Pharma Solutions Berhad Announces Appointment of Gan Yee Hin as Executive Director, Effective March 6, 2026 CI
02-27 Southern Score Builders Berhad completed the acquisition of additional 26.56% stake in Nova Pharma Solutions Berhad. CI
02-09 Nova Pharma Solutions Berhad Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-29 Nova Pharma Solutions Berhad Announces Change in Financial Year End CI
12-21 Southern Score Builders Berhad acquired 33% stake in Nova Pharma Solutions Berhad from Khoo Boo Wie for MYR 18.2 million. CI
11-21 Nova Pharma Solutions Berhad Announces First Interim Single-Tier Dividend of 8 Sen for the Financial Year Ending 31 December 2025, Payable on December 26, 2025 CI
25-08-25 Nova Pharma Solutions Berhad Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-02-24 Nova Pharma Solutions Berhad Reports Earnings Results for the Full Year Ended December 31, 2024 CI
24-11-25 Nova Pharma Solutions Berhad Announces First Interim Single Tier Dividend for the Financial Year Ending 31 December 2024, Payable on 27 December 2024 CI
24-08-26 Nova Pharma Solutions Berhad Reports Earnings Results for the Half Year Ended June 30, 2024 CI
24-02-22 Nova Pharma Solutions Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 CI
23-08-17 Nova Pharma Solutions Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2023, Payable on 15 September 2023 CI
23-08-16 Nova Pharma Solutions' Profit, Revenue Rise in H1 MT
Manager TitleAgeSince
Chief Executive Officer 56 2015-03-31
Sales & Marketing - -
Corporate Secretary - -
Director TitleAgeSince
Director/Board Member 56 2015-03-31
Director/Board Member 49 2014-12-31
Director/Board Member - 2020-06-30
Change 5-day change 1-year change 3-year change Capi.($)
+43.75%-14.81% - - 7.67M
+1.93%+2.07%+80.08%+237.49% 103B
-0.90%-3.59%-6.75%+17.60% 77.54B
+2.69%+4.69%+160.56%+891.48% 62.33B
-0.18%+0.44%+10.48%+52.66% 58.45B
-1.42%-3.24%+18.62%+86.68% 46.34B
-0.18%-2.08%+100.09%+379.44% 38.59B
+0.61%+2.37%+38.09%+278.70% 36.89B
-0.36%+0.46%+67.18%+247.51% 35.13B
-0.90%-2.65%-20.86%-25.68% 26.96B
Average +4.50%-0.21%+49.72%+240.65% 53.93B
Weighted average by Cap. +0.41%+0.10%+54.15%+250.23%
Logo Nova Pharma Solutions
Nova Pharma Solutions Berhad is a Malaysia-based company, which is engaged in the business of provision of technical documentation, validation, and project execution in the pharmaceutical and biological industries. It operates through four segments: Design, Post Design, engineering, procurement, construction, and commissioning (EPCC) and Other Support. The Design segment comprise conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment’s. The Post Design segment comprise tendering and procurement support as well as construction management of plant. The EPCC segment comprise of works and services pertaining to engineering, procurement, construction, and commissioning for advanced technology facilities. The Other Support segment comprise of services to assist customer in the manufacturing practice document review and gap analysis and assessment.
Employees
-